Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Note: All protein shipments include standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
The tag type is determined during production. If you require a specific tag type, please inform us, and we will prioritize its implementation.
KEGG: aga:AgaP_AGAP004191
STRING: 7165.AGAP004191-PA
The stability of recombinant A. gambiae MED22 depends on proper storage conditions. According to product specifications, liquid preparations should be stored at -20°C to -80°C with a typical shelf life of 6 months, while lyophilized forms can maintain stability for up to 12 months at the same temperature range .
For working with the protein:
Avoid repeated freeze-thaw cycles, which can cause protein degradation
Prepare small working aliquots and store at 4°C for up to one week
Reconstitute lyophilized protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (optimally 50%) before aliquoting for long-term storage
While specific protocols for A. gambiae MED22 are not widely published, researchers can adapt methods from successful purification of other mosquito proteins. Based on approaches used for tryptophan 2,3-dioxygenase (TDO) from A. gambiae , the following methodological considerations apply:
Expression system selection:
Purification strategy:
Affinity chromatography using the protein's fusion tag (His, GST, etc.)
Ion exchange chromatography for further purification
Size exclusion chromatography for final polishing
Quality control assessments:
To investigate the functional properties of A. gambiae MED22, researchers should consider these methodological approaches:
Transcription factor binding assays:
Electrophoretic mobility shift assays (EMSA) to detect DNA-protein complexes
Surface plasmon resonance (SPR) to measure binding kinetics with potential interacting proteins
Fluorescence anisotropy to quantify protein-protein interactions
Transcriptional activity assessment:
In vitro transcription assays using A. gambiae nuclear extracts supplemented with recombinant MED22
Reporter gene assays in cell culture systems to measure transcriptional activation
RNA-seq analysis following MED22 overexpression or knockdown
Structural studies:
X-ray crystallography to determine three-dimensional structure (if crystallizable)
Cryo-electron microscopy for structural analysis within the mediator complex
Hydrogen-deuterium exchange mass spectrometry to identify dynamic regions involved in protein interactions
Comparative analysis of MED22 across Anopheles species can provide insights into evolutionary conservation and functional importance. Methodological approaches include:
Sequence alignment and phylogenetic analysis:
Multiple sequence alignment of MED22 proteins from different Anopheles species
Construction of phylogenetic trees to visualize evolutionary relationships
Calculation of selection pressure (dN/dS ratios) to identify conserved functional domains
Comparative genomics approach:
Analysis of syntenic regions containing MED22 across Anopheles genomes
Identification of conserved regulatory elements in MED22 promoter regions
Examination of species-specific variations that may correlate with vector competence
This approach builds on genomic studies of Anopheles mosquitoes, which have revealed significant variation across the genus . The Anopheles genus has been extensively studied due to its importance in malaria transmission, with genome sequencing of multiple species providing valuable comparative data .
Investigating MED22's role in A. gambiae may reveal important aspects of mosquito biology relevant to vector competence. Methodological approaches include:
Tissue-specific expression analysis:
Functional genomics approaches:
CRISPR-Cas9 mediated gene editing to generate MED22 mutants
Assessment of phenotypic effects on development, reproduction, and immune response
Evaluation of impacts on susceptibility to Plasmodium infection
Transcriptional regulation studies:
Identification of genes regulated by MED22-containing mediator complexes
Analysis of transcriptional changes in response to blood feeding or Plasmodium infection
Investigation of MED22's role in regulating immunity genes
To investigate whether MED22 plays a role in mosquito-parasite interactions, researchers can employ these methodological approaches:
Infection studies with MED22-modified mosquitoes:
Molecular interaction studies:
Yeast two-hybrid screening to identify Plasmodium proteins that interact with MED22
Co-immunoprecipitation assays using antibodies against MED22
Protein microarrays to detect interactions between MED22 and parasite proteins
Transcriptomic analysis:
RNA-seq comparisons between wild-type and MED22-modified mosquitoes before and after Plasmodium infection
Identification of differentially regulated immune pathways
Validation of key targets using qRT-PCR and functional assays
Post-translational modifications (PTMs) often regulate protein function. To characterize PTMs of A. gambiae MED22:
Mass spectrometry-based approaches:
Tandem mass spectrometry (MS/MS) analysis of purified MED22
Phosphoproteomics to identify phosphorylation sites
Enrichment strategies for specific modifications (e.g., TiO₂ for phosphopeptides)
Biochemical assays:
Western blotting with modification-specific antibodies (phospho, acetyl, etc.)
In vitro enzymatic assays to identify potential modifying enzymes
Mutational analysis of predicted modification sites
Functional impact assessment:
Site-directed mutagenesis of identified PTM sites
Comparison of wild-type and PTM-mutant MED22 in transcriptional assays
Analysis of protein-protein interaction differences between modified and unmodified forms
Given the emergence of insecticide resistance in A. gambiae populations, investigating MED22's potential role requires systematic approaches:
Expression analysis in resistant strains:
Comparison of MED22 expression levels between insecticide-resistant and susceptible mosquito strains
Analysis of potential MED22 polymorphisms in resistant populations
Correlation of expression patterns with specific resistance mechanisms
Functional validation:
Transgenic overexpression or knockdown of MED22 followed by insecticide bioassays
Assessment of whether MED22 modulates expression of known resistance genes
Investigation of MED22's interaction with xenobiotic response pathways
Transcriptomic and epigenetic approaches:
ChIP-seq to identify genomic regions bound by MED22-containing complexes in resistant versus susceptible strains
RNA-seq to characterize transcriptional networks regulated by MED22
ATAC-seq to assess chromatin accessibility changes mediated by MED22
The development of genetic control strategies for A. gambiae could potentially incorporate MED22 research. Methodological considerations include:
Gene drive systems:
Assessment of MED22 as a potential gene drive target
Design of CRISPR-based constructs targeting MED22
Evaluation of fitness effects in laboratory cage trials
Regulatory elements for transgene expression:
Characterization of the MED22 promoter for potential use in driving transgene expression
Development of tissue-specific or conditional expression systems based on MED22 regulatory elements
Validation of expression patterns using reporter genes
Population genetics considerations:
Analysis of MED22 sequence variation across wild A. gambiae populations
Modeling of genetic control strategies targeting MED22
Assessment of resistance development potential through compensatory mechanisms
Understanding MED22's structure within the larger mediator complex requires sophisticated structural biology approaches: